PENTOSAN POLYSULFATE SODIUM (Elmiron®)
Clinical Indication
Bladder pain syndrome characterised by either glomerulations or Hunner’s lesions
Comments
In line with NICE TA610
Date of classification
July 2019
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.